BioSig to Highlight New Data from the PURE EP Platform at Heart Rhythm 2023

Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP Platform

May 3, 2023 — BioSig Technologies, Inc., a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that it will be presenting data at Heart Rhythm 2023, the Heart Rhythm Society's 44th annual meeting, on May 19-21, 2023, in New Orleans, Louisiana. At the meeting, new clinical data collected by the Company’s PURE EP Platform will be highlighted in three posters, presented by leading physicians from Cleveland Clinic.
BioSig will also be exhibiting at booth #2045 where the Company’s executive leadership, clinical and commercial teams will share customizable features and algorithms of the PURE EP Platform, showcasing intracardiac signal specificity unavailable on any other signal technology platform.

Abstract and Presentation Details Follow:

Friday, May 19, 2023 | 2:30-4:30 PM CT

Abstract: Unipolar Signal Modification-Guided Radiofrequency Ablation
Presenting Physician: Hagai Yavin, M.D., Research Fellow, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
First Author: Chadi Tabaja, MD

Saturday, May 20, 2023 | 1:30-3:30 PM CT

Abstract: Feasibility of Unipolar Signal Guided Ablation in Creating Contiguous Lines of Conduction Block: A Proof-of-Concept Study
Presenting Physician: Hagai Yavin, M.D., Research Fellow, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
First Author: Hagai Yavin, MD

DATE: TBD

Abstract: Comparison of Unipolar Electrogram Monitoring during Radiofrequency ablation in Viable and Ablated Myocardium: Loss of the S-component
Presenting Physician: TBD
First Author: Hagai D Yavin, MD

For more information: https://www.biosig.com/
Find more HRS23 conference coverage here